What question did this study set out to answer?

The research aims to explore the potential of manganese-activatable nanoparticles as immunotherapy agents for melanoma treatment.

March 25, 2026

Manganese-Activatable Nano-Hydroxyapatite Nanoparticles as Self-Adjuvanting STING Activators for Synergistic Melanoma Therapy

Key Points

The research aims to explore the potential of manganese-activatable nanoparticles as immunotherapy agents for melanoma treatment.
Developed manganese-activatable nano-hydroxyapatite nanoparticles
Evaluated their effect on the tumor microenvironment
Assessed synergistic effects with other treatments
Enhanced immune response against melanoma
Significantly reduced tumor growth
Improved therapeutic outcomes compared to conventional therapies

Abstract

The immunosuppressive tumor microenvironment in malignant melanoma presents a major therapeutic challenge, often leading to treatment failure of conventional monotherapies. This critical limitation underscores the urgent need for innovative biocompatible...

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Su Xiang

North Sichuan Medical University

Rong Yuan

North Sichuan Medical University

Yunjia Rao

North Sichuan Medical University

Journals

Journal of Materials Chemistry B

Actions

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Manganese-Activatable Nano-Hydroxyapatite Nanoparticles as Self-Adjuvanting STING Activators for Synergistic Melanoma Therapy

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study